There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
The group usually releases upbeat results with huge surprise rates.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
One of the major weak points of the company is its financial situation.
With an enterprise value anticipated at 4.44 times the sales for the current fiscal year, the company turns out to be overvalued.
With an expected P/E ratio at 34.38 and 29.07 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last few months, analysts have been revising downwards their earnings forecast.
For the past year, analysts have significantly revised downwards their profit estimates.